Goldman Sachs’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Sell
114,735
-85,266
-43% -$2.03M ﹤0.01% 4428
2026
Q1
$4.77M Buy
200,001
+179,914
+896% +$4.34M ﹤0.01% 3743
2025
Q4
$486K Sell
20,087
-41,457
-67% -$1M ﹤0.01% 5604
2025
Q3
$1.49M Buy
61,544
+49,000
+391% +$1.18M ﹤0.01% 4731
2025
Q2
$301K Buy
+12,544
New +$297K ﹤0.01% 5443
2024
Q4
Sell
-20,809
Closed -$501K 6142
2024
Q3
$501K Buy
+20,809
New +$496K ﹤0.01% 5049
2022
Q4
Sell
-52,447
Closed -$1.19M 6120
2022
Q3
$1.19M Buy
+52,447
New +$1.23M ﹤0.01% 4390

Other funds holding IBD

Goldman Sachs's IBD Position: Q2 2026 in Review

Goldman Sachs reduced its Inspire Corporate Bond ETF (IBD) stake by 43% in Q2 2026, selling an estimated $2.03M and leaving 114,735 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #4428.

Goldman Sachs first reported a position in IBD in Q3 2022 and has held it in 7 quarters since. The position peaked at $4.77M in Q1 2026. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Goldman Sachs held 114,735 shares of Inspire Corporate Bond ETF worth $2.73M as of Q2 2026.
  • Goldman Sachs sold 85,266 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $2.03M.
  • Inspire Corporate Bond ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4428 holding.
  • Goldman Sachs first reported a position in Inspire Corporate Bond ETF in Q3 2022 and has held it in 7 quarters since.
  • Goldman Sachs's Inspire Corporate Bond ETF position peaked at $4.77M in Q1 2026.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.